Back to mobile site

UPDATE: JPMorgan Upgrades Edwards Lifesciences (EW) to Overweight

December 17, 2021 3:40 AM EST Send to a Friend
(Updated - December 17, 2021 4:46 AM EST)

JPMorgan analyst Robbie Marcus upgraded Edwards Lifesciences (NYSE: EW) from Neutral ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login